Damien Foundation (DFB) is a non-profit medical organization that works with the Federal Government of Nigeria to combat tuberculosis (TB) and leprosy. Currently, Damien Foundation Nigeria covers a population of over 56 million across eight states (Oyo, Osun, Lagos, Ogun, Ekiti, Kwara, Ondo, and Edo states). The organisation is registered with the Corporate Affairs Commission (CAC) and has offices in Lagos and Ondo states, with its head office in Oyo State. DFB boasts a staff strength of 878, Adhoc staff inclusive.
The organization’s trademark is sterling service delivery in TB and leprosy diagnosis and treatment in close partnership with the ministries of health and other NGOs in the states where we operate.
For over 27 years, DFB has been offering technical support in the areas of capacity building in the management and diagnosis of tuberculosis and leprosy; infrastructural development of health facilities offering care and management of tuberculosis and leprosy. Notably, in 2010, DFB pioneered the treatment of Drug Resistance Tuberculosis (DR-TB) in partnership with the National Tuberculosis and Leprosy Control Programme (NTBLCP) and the University College Hospital, Ibadan (UCH) and remains the technical partner of the National Programme in the formulation of the TB treatment regimen in the country.
In the year 2014, DFB also pioneered the treatment of the Extensively Drug Resistance Tuberculosis (XDR-TB) at the Government Chest Hospital and, to date, remains the reference centre for XDR-TB cases in the country.
Damien Foundation procured the country's first fluorescent microscope sets and sponsored the Laboratory Scientist to international training on the use of cutting-edge technologies and quality service delivery. Furthermore, DFB constructed the South-West Zone TB Molecular Laboratory at UCH Ibadan and continues to support the smooth running of the facility to date.
Similarly, DFB offers technical assistance and funding for operational research on TB to formulate necessary policies for the improvement in diagnosis and management.
In 2021, DFB constructed and equipped the Damien Foundation Genomics and Mycobacteria Research and Training Centre at the University of Ibadan. DFB, through research, has formulated and advocates for a shorter regimen for the treatment of the disease.
DFB developed the first clinical guidelines and training curriculum for DR-TB and trained 95% of the entire health personnel managing DR-TB in the country. To stay abreast of best international practices, DFB constructed a world-class Drug Resistance Tuberculosis Treatment Centre at the University Teaching Hospital Ibadan (UCH) and remains committed to the capacity building of doctors and other health personnel in Chest X-Ray and COVID diagnosis and treatment.
In a bid to scale up TB case notification, diagnosis, prevention, and treatment services, DFB is in partnership with private health providers under the Global Fund Public-Private Mix (PPM) Grant. The goal of this initiative is to reduce the TB burden by complementing and accelerating existing TB activities in the country.become a volunteer